ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Septerna Inc

Septerna Inc (SEPN)

11.38
-1.79
(-13.59%)
Closed 12 February 8:00AM
11.30
-0.08
(-0.70%)
After Hours: 9:47AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
11.30
Bid
4.56
Offer
12.00
Volume
317,169
11.275 Day's Range 12.97
11.30 52 Week Range 28.99
Market Cap
Previous Close
13.17
Open
12.97
Last Trade
17
@
10.74
Last Trade Time
Financial Volume
US$ 3,833,258
VWAP
12.0859
Average Volume (3m)
312,999
Shares Outstanding
44,402,742
Dividend Yield
-
PE Ratio
120.72
Earnings Per Share (EPS)
0.09
Revenue
151k
Net Profit
4.18M

About Septerna Inc

Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by its proprietary Native Complex Platform. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the dis... Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by its proprietary Native Complex Platform. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Our lead product candidate, SEP-786, is a clinical-stage, oral small molecule agonist targeting PTH1R for the treatment of hypoparathyroidism. We have successfully completed Investigational New Drug (IND)-enabling studies and have initiated a Phase 1 clinical trial to assess preliminary safety, tolerability, PK, and PD of SEP-786. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Septerna Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SEPN. The last closing price for Septerna was US$13.17. Over the last year, Septerna shares have traded in a share price range of US$ 11.30 to US$ 28.99.

Septerna currently has 44,402,742 shares in issue. The market capitalisation of Septerna is US$584.78 million. Septerna has a price to earnings ratio (PE ratio) of 120.72.

SEPN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.76-24.966799468815.0616.15511.327118313.83021039CS
4-5.59-33.096506808816.8920.4811.324431816.06482324CS
12-11.71-50.890916992623.0128.9911.331299921.6796946CS
26-12.2-51.91489361723.528.9911.330693321.81985539CS
52-12.2-51.91489361723.528.9911.330693321.81985539CS
156-12.2-51.91489361723.528.9911.330693321.81985539CS
260-12.2-51.91489361723.528.9911.330693321.81985539CS

SEPN - Frequently Asked Questions (FAQ)

What is the current Septerna share price?
The current share price of Septerna is US$ 11.30
How many Septerna shares are in issue?
Septerna has 44,402,742 shares in issue
What is the market cap of Septerna?
The market capitalisation of Septerna is USD 584.78M
What is the 1 year trading range for Septerna share price?
Septerna has traded in the range of US$ 11.30 to US$ 28.99 during the past year
What is the PE ratio of Septerna?
The price to earnings ratio of Septerna is 120.72
What is the cash to sales ratio of Septerna?
The cash to sales ratio of Septerna is 3.34k
What is the reporting currency for Septerna?
Septerna reports financial results in USD
What is the latest annual turnover for Septerna?
The latest annual turnover of Septerna is USD 151k
What is the latest annual profit for Septerna?
The latest annual profit of Septerna is USD 4.18M
What is the registered address of Septerna?
The registered address for Septerna is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Septerna operate in?
Septerna operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AIFFFirefly Neuroscience Inc
US$ 8.34
(169.03%)
195.41M
SOPASociety Pass Inc
US$ 5.70
(119.23%)
52.99M
OMGAOmega Therapeutics Inc
US$ 0.1916
(77.41%)
319.92M
LTRYLottery com Inc
US$ 2.19
(76.61%)
56.53M
SHOTWSafety Shot Inc
US$ 0.1866
(58.81%)
2.82k
FTELFitell Corporation
US$ 1.00
(-53.49%)
7.43M
FLNCFluence Energy Inc
US$ 6.995
(-46.48%)
53.39M
BLACBellevue Life Sciences Acquisition Corporation
US$ 6.31
(-42.32%)
57.15k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 6.57
(-41.86%)
40.26k
CMCOColumbus McKinnon Corporation
US$ 20.885
(-41.14%)
4.57M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.090449
(31.09%)
1.12B
CYNCYNGN Inc
US$ 0.1605
(-13.10%)
922.9M
OCEAOcean Biomedical Inc
US$ 0.1999
(35.07%)
562.11M
OMGAOmega Therapeutics Inc
US$ 0.1916
(77.41%)
319.92M
INABIN8bio Inc
US$ 0.2951
(9.26%)
226.83M

Discussion

View Full Feed
chereb19 chereb19 37 seconds ago
There are no competitors to Radiogel n fantasy products don't count.
RDGL
chereb19 chereb19 1 minute ago
The door has gone there is so much interest in the shares. Your call for 5 cents a share is another shocker.
RDGL
op9171787 op9171787 2 minutes ago
Any way to tell if these are buys or sells?
IFAN
chereb19 chereb19 2 minutes ago
Plenty of places to check.like their SEC filings. Are you saying they are lying in them?
RDGL
janice shell janice shell 3 minutes ago
You don't have many allies left and you're not gaining dems nationally either

Patience. The half of the county that's below average will eventually realize Trump hasn't and won't make good on any of the promises he made.

Now go plant some potatoes.
fuagf fuagf 4 minutes ago
You calling a rational woman a harpy not a surprise. Cape Horn, a part of America, is not exactly
close to the Gulf of Mexico .. https://en.wikipedia.org/wiki/Extreme_points_of_South_America .
Lime Time Lime Time 5 minutes ago
Why not TA Verified? Seems like they have some decisions to make very quick. There is no escape once revocation proceedings start. File the Form 15 ASAP. It's a simple one page document.
RSPI
janice shell janice shell 8 minutes ago
Is it in any way involved in subsistence farming?
jeunke22 jeunke22 8 minutes ago
Lightwave Logic (LWLG) has a high percentage of its shares sold short . As of the latest data, 16.38% of its float (the number of shares available for trading by the public) is shorted . This means that a significant portion of its shares are held by investors betting that the stock price will decli
LWLG
TightCoil TightCoil 9 minutes ago
What do I see when I study this list?
I see High-Alltitude Action for the
rest of the week and nights of peaceful
sleep through the weekend. I might just take a little nap right now
FNMA
rbtree rbtree 11 minutes ago
Followed you over here. Worth doing some DD. methinx!!
MATEF
janice shell janice shell 13 minutes ago
Yes. The parallels really cannot be ignored.
WooptdooU WooptdooU 14 minutes ago
Reverse Split discussions legit...these scumbag grifters should get what the delivered...
LWLG
Renee Renee 16 minutes ago
TTOO: re institution holdings, most institutions have articles against holding common shares of an OTC security. Shareholders would need to contact the company to know if institutional holders of T2 Biosystems Inc needed or need to liquidate their holdings.

Check this link frequently
TTOO
Whalatane Whalatane 20 minutes ago
Ram its well established the confirmatory trials increase prescription rates .
AMRN does not need to run a full R-IT trial . Just a trial in the highest risk patients , large enough ( properly powered ) to generate stat sig results in the shortest time possible .
The R-IT trial was sta
AMRN
B402 B402 21 minutes ago
The B word...Lol, have a good one
Jp_SHMP Jp_SHMP 22 minutes ago
they are doing business only in china
USA have nothing to do with this except the listing for now

You talk big mouth don't know shit

JFHE is about internal spending in China for now at the start..

it's a startup but a good one

stop
IGPK
Fdc4 Fdc4 26 minutes ago
You are confused; didn’t you know I am your daddy? Mummy didn’t tell ya. Shut your cotton mouth kid and eat your doodles
IGPK
WooptdooU WooptdooU 27 minutes ago
The UNadmiral, return to the scene guy, doled out $5.6 MILLION (that is not a posting error) to the fake success (grifters) and is now in charge of budgeting??? Can you say cover up?
LWLG
k9uwa k9uwa 28 minutes ago
"Edo Richard – Alzheimer’s disease, dementia prevention and CHMP" NICE FIND Hosai. Really nice find. Edo being the top of the CHMP re: ALZ. More convinced I am than I was in 2015 that ANAVEX has the goods. Or as is commented here on IHub WTG.
Funny my primary care Physician last time around m
AVXL
boi568 boi568 28 minutes ago
Two major PD trials would certainly strain the company's balance sheet in the absence of cash flow.
AVXL
janice shell janice shell 30 minutes ago
I haven't researched it enough to understand exactly what the Chinese version is like...

Nor do I have all the answers, but the reading I've done suggests Dugin is interested in making subsistence farming available to all. Kind of the way things were in the 1930s Soviet Union. You're

Your Recent History

Delayed Upgrade Clock